PubMed Health⌕ Search

PubMed · 12656053

Technical needs assessment: UWMC's sensitivity analysis guides decision-making.

Abstract

In today's healthcare market, it is critical for provider institutions to offer the latest and best technological services while remaining fiscally sound. In academic practices, like the University of Washington Medical Center (UWMC), there are the added responsibilities of teaching and research that require a high-tech environment to thrive. These conditions and needs require extensive analysis of not only what equipment to buy, but also when and how it should be acquired. In an organization like the UWMC, which has strategically positioned itself for growth, it is useful to build a sensitivity analysis based on the strategic plan. A common forecasting tool, the sensitivity analysis lays out existing and projected business operations with volume assumptions displayed in layers. Each layer of current and projected activity is plotted over time and placed against a background depicting the capacity of the key modality. Key elements of a sensitivity analysis include necessity, economic assessment, performance, compatibility, reliability, service and training. There are two major triggers that cause us to consider the purchase of new imaging equipment and that determine how to evaluate the equipment we buy. One trigger revolves around our ability to serve patients by seeing them on a timely basis. If we find a significant gap between demand and our capacity to meet it, or anticipate a greater increased demand based upon trends, we begin to consider enhancing that capacity. A second trigger is the release of a breakthrough or substantially improved technology that will clearly have a positive impact on clinical efficacy and efficiency, thereby benefiting the patient. Especially in radiology departments, where many technologies require large expenditures, it is no longer acceptable simply to spend on new and improved technologies. It is necessary to justify them as a strong investment in clinical management and efficacy. There is pressure to provide "proof" at the department level and beyond. By applying sensitivity analysis and other forecasting methods, we are able to spend our resources judiciously in order to get the equipment we need when we need it. This helps ensure that we have efficacious, efficient systems--and enough of them--so that our patients are examined on a timely basis and our clinics run smoothly. It also goes a long way toward making certain that the best equipment is available to our clinicians, researchers, students and patients alike.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Michael Alotis. Technical needs assessment: UWMC's sensitivity analysis guides decision-making.. https://pubmed.ncbi.nlm.nih.gov/12656053/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Challenges in drug development for muscle disease: a stakeholders' meeting.

Current treatment benefits for patients with muscle disease are limited, but progress in legislative and scientific initiatives have set the stage for the development of new therapies. The MD-CARE Act (Public Law 107-84), which allocates federal resources to muscular dystrophy, was approved by Congress and signed into law by the President of the United States in 2001. This has shifted the emphasis toward translational research. To facilitate a push toward therapy for muscle disorders, the Muscular Dystrophy Association (MDA) sponsored a meeting with representatives from industry, the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and other government agencies and academia. Each contributed in different ways. The FDA helped define the necessary data to support investigational new drug (IND) applications including the design of proof-of-principle studies, outcome measures for clinical trials, and the pathway for developing surrogate measures for fast-tracking promising new drugs. The NIH, other government agencies, and the MDA described potential funding sources for translational research. Industry delineated a complementary role with academia, and academic investigators elucidated the current strengths and weaknesses of available clinical endpoints. The meeting provided a format for communication for diverse disciplines that usually have no common meeting ground, helping to lay the foundation for bringing products to market in a timely fashion.

Academic Medical Centers↗

Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.

BACKGROUND: Malaysia like many other countries worldwide uses spontaneous reporting systems as a mean of collecting data on suspected adverse drug reaction (ADR). However, compared to other countries, which use the system, the reporting rate in Malaysia is very low. Why some physicians do not report ADRs is not well understood. OBJECTIVE: To identify factors, which would predict physicians' failure to send ADR reports. DESIGN AND SETTING: Face-to-face interview using a structured questionnaire involving physicians working at the University of Malaya Medical Centre, Malaysia. RESULTS: About a third of the physicians in the Centre participated. Sixty-five of the 415 approached refused to participate. A high proportion of the respondents (81.4%) indicated that they had suspected an ADR but did not report it, while about 40% of the respondents were not aware of the existence of the national reporting system in Malaysia. Logistic regression modelling identified the variable 'ADR considered to be too trivial or too well known to report' as the strongest predictor of not reporting, followed by physicians' category and uncertainty that the reaction had been definitely caused by a drug. CONCLUSION: Important predictor variables, which limit physicians from reporting ADR in Malaysia, were related to uncertainty of types of reaction to report, lack of awareness about the existence, function and purpose of national ADR reporting. The findings could be useful for planning strategies to improve the reporting rate.

Academic Medical Centers↗